PatientPoint® has announced the purchase of MedCenterDisplay, a Nashville-based provider of digital signage, mobile apps and digital marketing solutions for hospitals. This latest acquisition solidifies the leadership position PatientPoint holds within the hospital sector and expands its suite of solutions to help hospitals communicate with and educate patients and, ultimately, enhance the patient experience. (read more)
Fluidigm Corporation (FLDM) and GenomOncology today announced a distribution agreement to co-market the GO Clinical Workbench™ for molecular interpretation of somatic variants identified using Fluidigm systems. An elegant solution for clinical research laboratories seeking accuracy, flexibility, and scalability, this combined offering will enable laboratories to achieve greater workflow efficiencies and productivity from NGS library preparation, variant annotation and reporting. (Read more)
Local company Kem Krest is pitching in to help parents of babies in intensive care.
The Elkhart company donated money for specialized cameras in Memorial Hospital’s NICU.
These cameras are a big deal to families. Parents and nurses faces light up when they talk about the Angel Eye system that’s now up-and-running. (Read More)
BioStable Science & Engineering, Inc. announced today that it has completed a direct de novo application to the U.S. Food and Drug Administration (FDA) for Class II designation of the HAART 300 Aortic Annuloplasty Device. Submission of the de novo request is an important milestone in BioStable’s efforts to bring the potential benefits of valve repair to U.S. patients suffering with aortic valve insufficiency. (read more)
GenomOncology today announced the recent extension of the GO Clinical Workbench™ to support Hematologic cancer testing and decision support.
Molecular diagnostic laboratories across the country have used GenomOncology’s workbench for their solid tumor testing needs for over two years. (read more)
Satchel Health, a company that uses connected devices to provide telehealth offerings to post-acute care providers, has raised just over $1 million in angel investments. The round was led by NueCura Partners, a healthcare-focused angel firm in Nashville, Tennessee, where Satchel is also based. (read more)
In the two years since it launched proprietary software solutions for next-generation sequence data analysis, GenomOncology has expanded its platform to include a number of additional applications that cater to a much broader range of analysis and interpretation needs. (read more)
Genomics England is partnering with GenomOncology, LLC (GO) to utilize the GO Knowledge Management System (GO KMS) as a tool for clinical reporting enablement. (read more)
NuSirt Biopharma, a company dedicated to improving the lives of those with chronic metabolic diseases, and One Way Liver S.L. (OWL Metabolomics), a leader in the field of metabolomics and liver diseases diagnostics, today announced they have initiated a strategic partnership to develop novel diagnostic tools for ongoing drug evaluation trials for NuSirt’s fatty liver drug research candidate, NS-0200. (read more)